BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Fiasp® (insulin aspart): new colour scheme for cartridges and pre-filled pens

Active substance: insulin aspart

The company Novo Nordisk Pharma GmbH is circulating information on the fact that a new colour scheme will be introduced for Fiasp® products as of July 2018 in order to improve their discernibility from Tresiba®.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 291KB, File is accessible